Overview

Phase I Study of CCRT as Adjuvant Treatment for Stage II/III Operable Rectal Cancer.

Status:
Unknown status
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the maximum tolerated dose and safety of S-1 plus radiotherapy for patients with rectal cancer
Phase:
Phase 1
Details
Lead Sponsor:
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University